Home/Filings/4/0001628280-24-052575
4//SEC Filing

Rubin Jonathan 4

Accession 0001628280-24-052575

CIK 0001356576other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:13 PM ET

Size

14.3 KB

Accession

0001628280-24-052575

Insider Transaction Report

Form 4
Period: 2024-12-27
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
  • Exercise/Conversion

    Performance Share Unit

    2024-12-271,8750 total
    Exercise: $0.00Common Stock (1,875 underlying)
  • Exercise/Conversion

    Common Stock

    2024-12-27+7505,822 total
  • Tax Payment

    Common Stock

    2024-12-27$35.59/sh281$10,0015,541 total
  • Tax Payment

    Common Stock

    2024-12-27$35.59/sh821$29,2196,595 total
  • Exercise/Conversion

    Common Stock

    2024-12-27+1,8757,416 total
  • Exercise/Conversion

    Performance Share Unit

    2024-12-277500 total
    Exercise: $0.00Common Stock (750 underlying)
Footnotes (6)
  • [F1]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023.
  • [F2]Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
  • [F3]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units.
  • [F4]Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024.
  • [F5]On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024.
  • [F6]On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1
  • filerCIK 0001836067

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 4:13 PM ET
Size
14.3 KB